You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR TAZAROTENE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for tazarotene

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00145106 ↗	Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris	Completed	Allergan	Phase 4	2002-03-01	The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗	Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris	Completed	Jefferson Medical College of Thomas Jefferson University	Phase 4	2002-03-01	The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗	Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris	Completed	Milton S. Hershey Medical Center	Phase 4	2002-03-01	The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗	Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris	Completed	New York University School of Medicine	Phase 4	2002-03-01	The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for tazarotene

Condition Name

Chart
Table

Condition Name for tazarotene
Intervention	Trials
Acne Vulgaris	22
Plaque Psoriasis	6
Psoriasis	5
Nail Psoriasis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for tazarotene
Intervention	Trials
Acne Vulgaris	23
Psoriasis	16
Keratosis	2
Cicatrix	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for tazarotene

Trials by Country

Map
Table

Trials by Country for tazarotene
Location	Trials
United States	136
Canada	6
India	2
Germany	1
Egypt	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for tazarotene
Location	Trials
Florida	12
California	12
Texas	11
Pennsylvania	8
North Carolina	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for tazarotene

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for tazarotene
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	8
Phase 2	14
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for tazarotene
Clinical Trial Phase	Trials
Completed	36
Terminated	4
Not yet recruiting	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for tazarotene

Sponsor Name

Chart
Table

Sponsor Name for tazarotene
Sponsor	Trials
GlaxoSmithKline	8
Stiefel, a GSK Company	8
Allergan	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for tazarotene
Sponsor	Trials
Industry	47
Other	35
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.